CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Rotigotine

Last Updated: July 31, 2013
Result type: Reports
Project Number: SR0344-000
Product Line: Reimbursement Review

Generic Name: Rotigotine

Brand Name: Neupro

Manufacturer: UCB Canada Inc.

Therapeutic Area: Parkinson's disease

Indications: Parkinson’s Disease

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: May 28, 2014

Recommendation Type: Do not list